We investigated the effect of membrane toxin 12 (MT-12), isolated from Naja naja atra, a species of Chinese Cobra, on the proliferation and invasion of human bladder cancer EJ cells and studied its mechanisms using MTT assay, Transwell chamber invasion assay, scanning electron microscopy and flow cytometry. The results indicated that MT-12 inhibited the proliferation of bladder cancer cells in a dose-dependent manner. The half maximal inhibitory concentration (IC 50 ) after 72 h was 0.66 µg/ml. The invasion of cells decreased with increasing doses of MT-12 (0.125-0.5 µg/ml, P<0.001). Expression of CXCR4 decreased with the effect of MT-12 for a particular concentration range (0.125-0.5 µg/ml). To conclude, MT-12 is capable of inhibiting the proliferation and invasion of bladder cancer EJ cells. This mechanism may be associated with reduced expression of CXCR4 protein.
Introduction
Invasion and metastasis are distinct features of malignant tumors, and metastasis is the main reason for failure of cancer treatment. Invasion and metastasis are affected by numerous factors, including the induction of angiogenesis, stroma adhesion, protein hydrolysis and movement, among others (1) . Urinary bladder cancer is one of the most common types of cancer, and postoperative chemotherapy remains the most important auxiliary treatment method. However, the effectiveness of chemotherapy is reduced due to the toxic side effects. Studies in vivo and in vitro have shown that membrane toxin (MT) is capable of killing a variety of tumor cells (2, 3) . Its anti-tumor mechanism is not yet completely understood, yet recent studies have shown that the destruction of the cell membrane structure and interference with DNA synthesis may be involved. Research also suggest that MT may be able to induce tumor cell apoptosis (4) . Research of the effects of MT on liver, lung, breast, melanoma and colorectal cancer is common (2, 3, 5) . However, there are few studies that have been carried out on bladder cancer. This experimental study of the effects of purified membrane toxin 12 (MT-12) on the human bladder cancer EJ cell line is reported as follows. Study apparatus and reagents were obtained as follows: FACSCalibur flow cytometer (Becton Dickinson Co., USA); a 5% CO 2 incubator and centrifuge volume fraction (ThermoFisher Scientific, Germany); a Bio-Rad 450 microplate reader, an electronic balance (Test Instrument Changshu Double Jay); and an S-3000N scanning electron microscope; a volume fraction of 2.5% glutaraldehyde; mouse anti-human CXCR4 fluorescent antibody (Santa Cruz Biotechnology, Inc., CA, USA); CXCR4 goat anti-mouse monoclonal antibody (Santa Cruz Biotechnology, Inc.); RPMI-1640 (Gibco, Invitrogen, Paisley, UK).
Materials and methods

Materials
Cell culture. The improved MTT method was used to study the effect of MT-12 on the proliferation of EJ cells as previously described (6) . After the EJ cells reached the logarithmic growth phase, the cell concentration was adjusted to 5x10 4 /ml and the cells were added into a 96-well plate, 90 µl/well. A total of five concentrations of MT-12, 0.0625, 0.125, 0.25, 0.5 and 1 µg/ml, were used and each concentration was set in three parallel wells, 10 µl/well. Soluble enzyme groups were constructed using 0.1 and 0.05% sodium chloride solution of equal volume. Negative control groups were constructed using 10 µl 10% (volume) serum-free RPMI-1640, while blank control groups were constructed using 100 µl of the above Effect of membrane toxin 12 isolated from Naja naja atra on proliferation and invasion of human bladder cancer EJ cells DELIN 
Construction of the invasion chamber and determination of invasiveness in vitro.
In order to prepare the chemokine, NIH3T3 cells were cultured in a 5% (volume fraction) CO 2 incubator at 37̊C. When the cell density reached 90%, the culture medium was discarded, serum-free RPMI-1640 was added and cells were placed in a 5% (by volume) CO 2 incubator at 37̊C for 24 h. The cells were centrifuged for 10 min at the rate of 800 rpm, and the supernatants were collected. They were stored in the refrigerator at -20̊C. A total of 100 µg Matrigel was diluted (1:8) and used to evenly coat a Transwell chamber and was formed into colloidal particles by being cultured in a 5% (volume fraction) CO 2 incubator at 37̊C for 20 min. We then placed the chamber on a clean desk under ultraviolet radiation overnight in order to obtain a dry and sterile Matrigel. The following day, we slowly added RPMI-1640 (300 µl) (with a small trickle), and placed it in a 5% (volume fraction) CO 2 incubator at 37̊C for 30 min, allowing the Matrigel to re-hydrate. The serum-free 1640 was aspirated, and 200 µl EJ cell suspension fluid was added. The cell number was 2x10 5 /ml. We then added the prepared prechemokines into the chamber (24-well culture plate), 600 µl/ well and placed the Transwell in 24-well plates. We added the various concentrations (0.125, 0.25, 0.5 µg/ml) of MT-12 into the chamber and these were defined as the experimental groups. An equal volume of saline was used to treat the plasmin control group (10 µl/well). They were cultured in a 5% (volume fraction) CO 2 incubator at 37̊C for 12 h. After this time, the samples were removed and the nutrient solution was discarded. The cells were fixed with 90% (by volume) ethanol for 10 min. The cells that did not pass through the cell membrane were wiped off carefully, and stained with 1 g/l crystal violet at room temperature for 10 min, and excess dye was rinsed clean with phosphate-buffered saline (PBS); 3 wells in each set. We then counted the number of invading cells under the microscope, a total of 12 fields, and the images were captured (x200 magnification) and calculated the number of invasive cells. The inhibition rate of cell invasion was calculated by the following formula: Inhibition rate (%) = (invasive cell count control well -invasive cell count experimental well )/invasive cell count control well x 100%.
Scanning electron microscopy. The optimal concentration of the MT-12 group in the experimental group was 0.5 µg/ml, and the vehicle control group was designed using an equal volume of saline. After 12 h, we removed the cells from the invasion chamber and added 2.5% (by volume) glutaraldehyde fixative to fix cells. We then observed the chamber invasion under a scanning electron microscope.
CXCR4 expression detected by flow cytometry. Bladder cancer cells were routinely cultured to the logarithmic phase, conventionally digested, adjusted to the concentration of 1x10 7 /ml and seeded in 6-well plates (2 ml/well). After 24 h, the time at which cells adhered to the 6-well plates, we added MT-12. The eventual concentrations of the experimental groups were 0.5, 0.25, 0.125 µg/ml, respectively, and the control groups with saline were also fixed. After 24 h, cells were prepared by trypsin digestion to the cell suspension (concentration of 1x10 6 /ml). Fluorescein-labeled CXCR4 monoclonal antibody 5 µl was added into 100 µl cell suspension, and another 100 µl cell suspension was set as a control group. CXCR4 expression was determined by flow cytometry.
Statistical analysis.
For the experimental data, SPSS 11.5 statistical package was used for ANOVA. Differences were significant at a P-value <0.05.
Results
MT-12 inhibits EJ cell proliferation in vitro.
After the EJ cells were treated with MT-12 for 72 h, the cell proliferation was significantly inhibited in a concentration-dependent manner (Table I ). The half inhibitory concentration (IC 50 ) was 0.66 µg/ ml.
Effect of MT-12 on invasiveness of EJ cells.
Transwell invasion results revealed that EJ cells were capable of passing through the Matrigel matrix, which was covered by an artificial plastic polycarbonate membrane. In the plasmin control group, a large number of EJ cells permeated to the other side of the Transwell membrane. However, in the MT-12 experimental groups, the number of EJ cells that permeated to the other side of the Transwell membrane was reduced in a concentration-dependent manner (Figs. 1 and 2) .
Scanning electron microscopy. The polycarbonate membrane covered with Matrigel was observed. Pores on the polycarbonate membrane were closed by plastic Matrigel. In vitro, the volume of bladder cancer EJ cells was relatively large and cells were oval in shape. EJ cells crossed through the Matrigel and the pores of the polycarbonate membrane and attached to the back of the Matrigel. In the control groups, the tumor cells had more microvilli and extended pseudopodia. In the experimental groups, the tumor cells had fewer surface microvilli and shorter pseudopodia (Fig. 3) .
Effect of MT-12 on the CXCR4 protein expression of EJ cells.
Compared with the control groups, the expression of CXCR4 decreased with the effect of MT-12 at a certain concentration range (0.125-0.5 µg/ml). However, there was no significant difference between the expression of CXCR4 and concentrations of MT-12 in this concentration range (Fig. 4) .
Discussion
Bladder carcinoma is a common genitourinary cancer, and its malignant features of recurrence and metastasis are resistant to clinical treatments. The mechanism of tumor invasive growth is not yet clear. Invasion and metastasis are the main features of malignancy. In tumor cell migration, invasion and metastasis, chemokines and their receptors play essential roles. Chemokines refer to a large family with chemotactic cytokine chemicals. According to the end of the first two adjacent amino acid tyrosine positions, chemokines may be be divided into four categories: CXC, CC, C and CX3C. Through G protein-coupled transmembrane receptors, chemokines are able to play a role in tumor cell invasiveness. In 2001, Muller et al found that human breast cancer cell lines, breast cancer primary tumors and metastases highly expressed the chemokine receptors CXCR4 and CCR7 (7). CXCR4 is a G protein-coupled receptor, which consists of seven transmembrane domains. Recent research has revealed that this protein is known as a coreceptor for a foreign HIV. The expression of the chemokine receptor, CXCR4, has been shown to play a key role in migration and metastasis associated with tumor progression, and is associated with poor prognosis in a limited number of malignancies (8) (9) (10) (11) . We speculated that the expression of CXCR4 in malignant tumors may also be related to bladder cancer, and this role of CXCR4 makes it a potential target for prevention and treatment of tumor metastasis.
MTT results of this study revealed that MT-12 is capable of inhibiting the proliferation and invasion of human bladder cancer EJ cells in a dose-dependent manner; the IC 50 of EJ growth was 0.66 µg/ml. Tumor cells must destroy the extracellular matrix and basement membrane in order for metastasis to occur. Matrigel gel used in this study was similar to the extracellular matrix components and is capable of effectively stimulating the process of tumor cell invasion in vitro. The results of this study demonstrated that MT-12 inhibited the invasion of EJ cells compared with the negative control group, and with increases in MT-12 concentration, this inhibition efficiency was more marked, revealing that this occurred in a dose-dependent manner. When the concentration of MT-12 was 0.125, 0.25 and 0.5 µg/ml, respectively, the invasion inhibition rates of EJ cells were 43.31, 55.30 and 78.29%, which was significantly different compared with the control group (P<0.001). MT-12 at the 0.25 µg/ml concentration revealed a significant inhibitory effect and the invasion inhibitory rate was 55.30%. However, at this concentration, the proliferation rate of EJ cells was 9.50%. This suggested that the inhibition of EJ cell invasion was not significantly correlated with its cytotoxicity, and that inhibition appeared to be more sensitive. By using scanning electron microscopy, the process of invasion in vitro was observed. The characteristics of tumor cell invasion and the Matrigel assay was confirmed, providing a theoretical support for future research.
In conclusion, MT-12 is capable of inhibiting proliferation and invasion of bladder cancer cells. Furthermore, CXCR4 expression decreased compared with the control group. This enables us to make tentative assumptions that MT-12 is able to reduce the proliferation and invasion of bladder cancer EJ cells and may achieve this by reducing the expression of CXCR4. However, the related mechanisms of this inhibition must be studied in more detail.
